The preliminary experiment research of correlation between plasma miRNA expression spectrum and cervical cancer

Xiuyun Xu,Ying Hong

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.13.017

2014-01-01

Abstract:ObjectiveTo explore the expression level of plasma miRNA expression difference in patients with cervical cancer and the expression difference in different clinical stages; To evaluate the plasma microRNAs in the diagnosis of cervical cancer.Methods From January 2013 to June 2013, we selected 12 women who had already been diagnosed cervical invasivecancer by cervical biopsy, diagnostic conization and pathohistology in department of gynecology of Nanjing Drum Tower Hospital. At the same time, we selected 12 cases of community medical staff as the control group. The two groups of screening of microRNAs in plasma, we used real-time fluorescent quantitative PCR method for testing, then the data will be analyzed by the independent samplettest.Results The test result from the independent test data set showed that there was a significant expression difference in cervical cancer group and the control group of miR-21,miR-34a,miR-200a and miR-214, and miR-21, miR-200a, miRNA-214 to express present differences in cervical cancer clinical stage. Receiver operating characteristic curve (ROC) can be drew, the area under the ROC curve (AUC) between 0.7-0.9, 0.767, 0.826, 0.874 and 0.727, respectively, showed that the four plasma microRNAs markers had certain accuracy.Conclusions Plasma miR-21, miR-34a, the miRNA-200-a has high expression in patients with cervical cancer, while the miRNA-214 low expression. Plasma miR-21, the miRNA-200-a in late cervical cancer (Ⅱb and above) expression than early cervical cancer (Ⅰa -Ⅱa) expression is higher, the miRNA-214 in the late cervical cancer (Ⅱb and above) expression than early cervical cancer (Ⅰa -Ⅱa) expression. Screening of microRNAs in the diagnosis of cervical cancer has certain accuracy.